Driving breakthrough discoveries for better healthcare outcomes.
Explore SPARC’s work in action, including panel discussions, articles, and more.
As genetic research advances, questions remain about how this knowledge translates into better treatments and care. This panel examines successes, challenges, and future directions in using genetics to inform medicine.
SPARC conducted a landscape analysis of health equity in science to identify where philanthropy can drive meaningful change. The Giving Smarter Guide outlines key trends, barriers, and opportunities to advance more equitable research and health outcomes.
Collaboration and community are vital in tackling rare diseases like sarcoidosis. This piece highlights how new initiatives are connecting researchers, patients, and funders to drive progress.
This Giving Smarter Guide highlights how philanthropy can use AI to accelerate precision medicine in neurodegenerative disease research and care.
A new SPARC report, commissioned by The 10,000 Brains Project, highlights how AI and precision medicine can transform neurodegenerative disease research.
Neurodegenerative diseases affect over 50 million people worldwide. In partnership with the 10,000 Brains Project, SPARC mapped how AI and precision medicine can transform research and accelerate progress toward better treatment.
LHON causes sudden, irreversible blindness. SPARC’s partnership with the LHON Collective and the Giving Smarter Guide highlights how philanthropy can accelerate research, foster collaboration, and drive progress toward treatments that restore vision and improve lives.
There are no treatments to prevent or reverse LHON vision loss. SPARC’s Giving Smarter Guide shows how philanthropy can drive progress toward new discoveries.
The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program, in partnership with SPARC), announced six research teams awarded two-year grants to advance scientific understanding of FTD.
SPARC examines recent advances in sarcoidosis research, from progress toward a simple blood test to new treatment options and insights into cardiac sarcoidosis. The piece highlights the impact of philanthropic funding, key research collaborations, and efforts to improve clinical trial diversity.